CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma

Clinical trial NCT02336386 · UNKNOWN

Trial details

NCT number: NCT02336386
Sponsor: Beijing Chao Yang Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Extramedullary Plasmacytoma

Start date: 2014-12-01
Primary completion: 2016-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.